Amendment to Regulation (EU) 2024/795
2025/0102(COD)
Monitoring and controlling drug precursors and repealing Regulations (EC) No 273/2004 and (EC) No 111/2005
2025/0384(COD)
Amendment to Regulation (EU) 2017/1001 (+2 more)
2023/0127(COD)
Amendment to Regulation (EC) 816/2006
2023/0129(COD)
Medicinal Product Authorisations
2024/2653(DEA)
EMA Fees & Charges
2022/0417(COD)
Medicinal Product Labelling (Amendment)
2022/2819(DEA)
EMA Fee Inflation Adjustment
2022/2730(DEA)
Medicinal Products Derogations
2021/0431(COD)
Medicinal Products Derogation (Amendment)
2021/0432(COD)
EMA Crisis Management Role
2020/0321(COD)
UK Medicine Exports: Decommissioning
2021/3053(DEA)
EU Pharmaceutical Strategy
2021/2013(INI)
Medicinal Safety Features (Amendment)
2021/2800(DEA)
Medicine Marketing Authorisations
2021/2616(DEA)
Transparent Mask Distribution
2021/2519(RSP)
UK Export: Unique Identifier Derogation
2021/2510(DEA)
COVID-19 vaccinations
2021/2500(RSP)
EU Pharmaceutical Strategy
2020/2878(RSP)
EMA Fees: Inflation Adjustment
2020/2725(DEA)
COVID-19 GMO Clinical Trials
2020/0128(COD)
Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and
2014/0256(COD)
EMA Pharmacovigilance Fees
2017/2923(DEA)
GMP: Investigational Medicinal Products
2017/2710(DEA)
Medicine Trade Diversion
2014/0165(COD)
The packaging of medicinal products for human use
2015/2890(DEA)
Drug precursors and (EC) No 111/2005 laying down rules for the monitoring of trade between the Union and third
2015/2669(DEA)
GMP: Active Substances (Human)
2014/2759(DEA)
EMA Pharmacovigilance Fees
2013/0222(COD)
IMI2 Joint Undertaking
2013/0240(NLE)
Drug precursors
2013/0005(NLE)
Medicinal products for human use (Repeal)
2012/0192(COD)
Medicine Efficacy Studies
2014/2562(DEA)
Drug Precursor Trade
2012/0250(COD)
Drug precursors (Amendment)
2012/0261(COD)
Pharmacovigilance (Amendment)
2012/0023(COD)
EGF: AstraZeneca
2012/2155(BUD)
Pharmacovigilance (Amendment)
2012/0025(COD)
PIP Breast Implants
2012/2621(RSP)
Asthma Inhalers
2010/2962(RSP)
Duty-Free Pharma Ingredients
2010/0214(COD)
Medicine Authorisation Variations
2008/0045(COD)
Medicinal SPCs (Codified)
2008/0126(COD)
Medicinal Product Colouring
2008/0001(COD)
The Commission)
2006/0295(COD)
Innovative Medicines Initiative JU
2007/0089(CNS)
Advanced Therapy Medicines
2005/0227(COD)
Medical devices
2005/0263(COD)
Paediatric Medicines
2006/0207(COD)
Paediatric Medicines
2004/0217(COD)
Medicinal Product Counterfeiting
2006/2575(RSP)
Pharma Licenses: Public Health
2004/0258(COD)
EMA Fees
2005/0023(CNS)
Pandemic Flu Strategy
2005/2627(RSP)
Herbal Medicines (Amendment)
2002/0008(COD)
Medicinal Products & EU Agency
2001/0252(COD)
Medicinal Products Code (Amendment)
2001/0253(COD)
Medical Devices Directive Health Impact
2001/2270(INI)
Chemical substances (codified version)
2002/0231(COD)
WTO: Generic Drug Authorization
2003/2514(RSP)
HIV/AIDS Meds Access
2001/2531(RSP)
Human Medicinal Products Code
1999/0134(COD)
Medicinal products for human use
1997/0197(COD)
Ozone-Depleting Medical Devices
2000/0175(COD)
Orphan Drugs
1998/0240(COD)
EMA Fees (Amendment)
1998/0135(CNS)
IVD Standardization Rules
1995/0013(COD)
EMA Financial Regulation
1994/0220(CNS)